Delivra Health Brands Inc. provides lifestyle and wellness products, primarily in the cannabis sector. While the company has a strong liquidity position with a current ratio of 3.29, it faces significant profitability challenges, reflected in negative EBITDA and net margins of -78.4% and -82.4%, respectively. The market cap of $2.66M and a recent price drop of 10.53% raise concerns about investor confidence. Overall, the financial health score of 54 indicates potential, but the company must address its operational losses to improve its outlook.
Loading financial metrics...
Revenue decreased 10.7% year-over-year from $12.6M to $11.2M.
Excellent liquidity with current ratio of 3.3x ensures operational stability.
Strong balance sheet with net cash position provides cushion for growth investments.
Low debt-to-revenue ratio of 20.8% indicates conservative financial management.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2026-Q3 (March 31, 2026)